New & Niche Drugs
from OncoPharm Hosted by John Bossaer
We finish discussing the 2018 FDA-approvals (calaspargase, ravulizumab, tazgraxofusp).
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of OncoPharm?
This episode is 13 minutes long.
When was this OncoPharm episode published?
This episode was published on January 10, 2019.
Can I download this OncoPharm episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.